Testing the efficacy of a decision aid and planning tool for family building after cancer
测试癌症后家庭建设决策辅助和规划工具的功效
基本信息
- 批准号:10715548
- 负责人:
- 金额:$ 63.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-08 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAftercareAgeAreaAssisted Reproductive TechnologyBehaviorBehavioral MechanismsBehavioral ModelBeliefCancer SurvivorCancer SurvivorshipCaringCategoriesChildClinicClinicalCommunicationComputer softwareConflict (Psychology)Continuance of lifeControl GroupsCounselingDataDecision AidDecision MakingDistressEmotionalEmotionsEnsureFamilyFemaleFertilityFertilization in VitroFutureGenerationsGoalsGynecologyHigh-Risk CancerInfertilityInterventionIntervention TrialInterviewKnowledgeLegalMalignant NeoplasmsMediatingMediatorMedicalMissionModelingMotivationOncologyOnline SystemsPamphletsPatientsPilot ProjectsPregnancyPremature MenopausePrimary CareProviderQuality of lifeRandomizedRandomized, Controlled TrialsRecommendationRecording of previous eventsReportingReproductive HealthReproductive MedicineResearchResourcesRiskSelf EfficacySurveysSurvivorsTestingTimeTraumaTreatment EfficacyUnited States National Institutes of HealthWomanWorkacceptability and feasibilityassigned female at birthattentional controlcancer therapycomparison controlcostefficacy testingefficacy trialexpectationexperiencefamily buildingfertility preservationfollow-upfuture implementationgroup interventionimplementation facilitatorsimplementation interventionimprovedintervention effectmedical specialtiesnoveloncofertilitypatient-clinician communicationpilot testpreferencepregnantprimary outcomeprovider communicationpsychosocialreproductivesecondary outcomeskillssuccesssurrogacysurvivorshiptherapy developmenttoolweb based decision aidyoung adult
项目摘要
Project Summary/Abstract
Up to 93% of young adult female (YA-F) cancer survivors report fertility distress; 30-46% meet criteria for
moderate-severe fertility-related trauma. Gonadotoxic cancer treatments can cause infertility, early
menopause, or problems getting pregnant and carrying a pregnancy to term. Family building after cancer often
requires in vitro fertilization, surrogacy, or adoption, which have medical/physical, psychosocial, financial, legal,
and logistical barriers. Prior work shows that YA-Fs are unprepared for the challenges of family building after
cancer, have unrealistic expectations (such as overestimating the likelihood of success), and risk missing their
narrowed reproductive window and experiencing greater difficulty, distress, and higher costs than expected.
The long-term goal of the proposed research is to improve oncofertility care in post-treatment survivorship. We
propose to test the efficacy of the Roadmap to Parenthood software, an interactive web-based decision aid
and planning tool for family building after cancer for YA-F survivors (18-45 years old; assigned female at birth)
and explore its implementation potential. First, we will conduct a rigorous 12-month randomized controlled trial
(Aim 1). YA-F cancer survivors (N=256) will be randomized into the (a) Roadmap intervention condition or (b)
time and attention control condition that includes a web-based young adult cancer survivorship informational
booklet. Surveys will be administered at baseline (pre-intervention) and 1-, 6-, and 12-month follow up
timepoints. We hypothesize the intervention group compared to the control group will report lower decisional
conflict about family building (primary outcome), more planning behaviors aligned with family-building goals
(e.g., fertility testing, financial planning), and improved quality of life (secondary outcomes). Then, we will test
mediators and moderators of intervention efficacy (Aim 2). We hypothesize age, partnership status, fertility
preservation history, and engagement with the decision aid will moderate the relationship between the
intervention and decisional conflict, and increased levels of knowledge and self-efficacy and improved
communication with providers will mediate the intervention effect on decisional conflict. Finally, we will evaluate
future implementation potential of the Roadmap tool in clinical settings (Aim 3). Guided by the Capability-
Opportunity-Motivation Behavior (COM-B) implementation model, we will conduct qualitative interviews with
providers representing four specialties (N=32; 8 from each) to understand barriers and facilitators to the
implementation of the Roadmap tool across clinics. Providers working in diverse settings in oncology, primary
care, gynecology, and reproductive medicine, all of whom address reproductive health clinically, will be
included. Themes related to barriers/facilitators within the categories of ‘capability’ (e.g., skills, knowledge),
‘opportunity’ (e.g., resources), and ‘motivation’ (e.g., emotion, beliefs) will be identified. This research will
comprehensively respond to the identified needs of YA-F survivors that hope to have a child after cancer
through a novel intervention that provides information and support for decision making and early planning.
项目总结/摘要
高达93%的年轻成年女性(YA-F)癌症幸存者报告生育困难; 30-46%符合以下标准:
中重度生育相关创伤性腺毒性癌症治疗可导致不孕症,早期
更年期,或怀孕和怀孕到足月的问题。癌症后的家庭建设往往
需要体外受精,代孕,或收养,这有医疗/身体,心理,财务,法律的,
后勤障碍。先前的研究表明,青年女性在经历了一段时间的家庭建设之后,
癌症,有不切实际的期望(如高估成功的可能性),并有错过他们的风险。
生殖窗口缩小,经历比预期更大的困难、痛苦和更高的成本。
拟议研究的长期目标是改善治疗后生存率的肿瘤生育护理。我们
我建议测试父母身份路线图软件的有效性,这是一个基于网络的交互式决策辅助工具
为YA-F幸存者(18-45岁;出生时指定为女性)提供的癌症后家庭建设规划工具
并探索其实施潜力。首先,我们将进行一项为期12个月的严格随机对照试验
(Aim 1)。YA-F癌症幸存者(N=256)将被随机分配至(a)路线图干预条件或(B)
时间和注意力控制条件,包括基于网络的年轻成人癌症生存信息
小册子。将在基线(干预前)和1个月、6个月和12个月随访时进行调查
时间点。我们假设干预组与对照组相比,
关于家庭建设的冲突(主要结局),更多的计划行为与家庭建设目标一致
(e.g.,生育测试、财务规划)和改善生活质量(次要结果)。然后,我们将测试
干预效果的中介者和调节者(目标2)。我们假设年龄,伴侣关系,生育能力
保存历史以及与决策辅助的参与将缓和
干预和决策冲突,提高知识水平和自我效能,
与提供者沟通对决策冲突的干预效果起中介作用。最后,我们将评估
路线图工具在临床环境中的未来实施潜力(目标3)。以能力为导向,
我们将进行定性访谈,
代表四个专业的供应商(N=32;每个专业8名),以了解
路线图工具在各诊所的实施。在不同环境中工作的提供者,主要
护理,妇科和生殖医学,所有这些都涉及生殖健康临床,将是
包括.与“能力”类别中的障碍/促进因素有关的主题(例如,技能、知识),
“机会”(例如,资源)和“动机”(例如,情感、信念)将被识别。这项研究将
全面回应希望在癌症后生育孩子的YA-F幸存者的明确需求
通过一种新的干预措施,为决策和早期规划提供信息和支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Benedict其他文献
Catherine Benedict的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Benedict', 18)}}的其他基金
Family-building After Cancer: Preferences, Decisions, and Planning for Young Female Survivors
癌症后的家庭建设:年轻女性幸存者的偏好、决定和规划
- 批准号:
9973157 - 财政年份:2018
- 资助金额:
$ 63.29万 - 项目类别:
Family-building After Cancer: Preferences, Decisions, and Planning for Young Female Survivors
癌症后的家庭建设:年轻女性幸存者的偏好、决定和规划
- 批准号:
10573131 - 财政年份:2018
- 资助金额:
$ 63.29万 - 项目类别:
Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment
为考虑治疗后未来家庭建设的青少年和年轻女性癌症幸存者开发决策辅助工具
- 批准号:
9233234 - 财政年份:2017
- 资助金额:
$ 63.29万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.29万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Standard Grant














{{item.name}}会员




